title: Species-specific sensitivity of coagulase-negative Staphylococci to single antibiotics and their combinations.
abstract: The activity of beta-lactam antibiotics (oxacillin, cloxacillin, cephalotin), vancomycin, gentamicin and rifampicin applied in vitro individually and in combination against 37 nosocomial methicillin-resistant strains of coagulase-negative staphylococci (CNS) was assessed to demonstrate the heterogeneity of this group of bacteria and estimate the chance of the efficacy of such therapy. The strains belonged to four species: Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus cohnii, Staphylococcus hominis. They originated from a hospital environment and from the skin of medical staff of the intensive care unit of a paediatric ward at a university hospital. All strains were methicillin-resistant, according to CLSI standards, but individual strains differed in MIC(ox) values. Susceptibility to other tested antibiotics was also characteristic for the species. The increased susceptibility to antibiotics in combinations, tested by calculating the fractional inhibitory concentration (FIC) index, concerned 26 out of 37 investigated strains and it was a feature of a particular species. Combinations of vancomycin and cephalotin against S. epidermidis and oxacillin with vancomycin were significant, as well as cephalotin and rifampicin in growth inhibition of multiresistant S. haemolyticus strains.
authors: Department of Biosynthesis of Drugs, Medical University of Łódź, Poland. grazyna.szymanska@umed.lodz.pl
authors: Grazyna
authors: G
authors: Szymańska
authors: Magdalena
authors: M
authors: Szemraj
authors: Eligia M
authors: EM
authors: Szewczyk
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002648:Child; D003428:Cross Infection / Q000382:microbiology; D004357:Drug Synergism; D006785:Hospitals, University; D006801:Humans; D015278:Intensive Care Units, Pediatric; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D011044:Poland; D013045:Species Specificity; D013203:Staphylococcal Infections / Q000382:microbiology*; D013210:Staphylococcus / Q000145:classification / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents